Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Affirmation cards may ease labor pain and fear in First-Time mothers

NCT ID NCT07542392

Symptom relief Sponsor: KTO Karatay University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether midwife-guided birth affirmation cards can help first-time mothers have a better childbirth experience. Researchers will measure labor duration, pain, fear, and feelings of control and support in 60 women. The goal is to see if this simple, non-drug approach improves labor outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having a singleton pregnancy between 37-42 weeks of gestation * Being between 18-40 years of age * Being a primigravida * Having a cephalic presentation with vertex position * Being in the active phase of labor (cervical dilatation ≥4 cm) * Accepting non-invasive interventions * Having no mental or physical disability * Being able to understand and speak Turkish * Willingness to participate in the study Exclusion Criteria: * High-risk pregnancies * Pregnant women at risk of intrapartum complications (e.g., oligohydramnios, polyhydramnios, intrauterine fetal demise, placenta previa, placental abruption, acute fetal distress, preeclampsia, fetal dystocia, macrosomia, etc.) * Pregnant women with a history of medical or obstetric complications * Women who have attended antenatal education classes (pregnancy school) * Women using epidural analgesia or other pharmacological pain management methods * Women experiencing communication difficulties * Women who are unwilling to participate in the study Exclusion Criteria from the Study * Experiencing dizziness, shortness of breath, or other discomfort, * Difficult and prolonged labor, instrumental delivery, placental retention, postpartum hemorrhage, need for neonatal intensive care, * Situations requiring emergency cesarean section during labor, * The woman will be excluded from the study if she ceases to cooperate during labor.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Control (internet only) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Labor Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Control (internet only) Duration of labor Fear of childbirth Labor pain Support

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mut Devlet Hastanesi

    RECRUITING

    Mut, Mersi̇n, 33600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.